FSRH Response to new study on use of CHC and POC and breast cancer risk (March 2023)

Published on: 22 March 2023

File size: 412kb PDF

File type: Clinical Statements

This statement is a response to a new observational study by Fitzpatrick et al. (March 2023) which investigated the association between current or recent use of combined oral and progestogen-only hormonal contraception and breast cancer risk.

Your download should start automatically. If not download directly.